Marion Jurk

Marion Jurk

Senior Director Preclinical Research @ DEBRA Research

About

Excellent and committed executive with 22+ years’ experience in biotech and pharma industry. Profound knowledge in the development of cell and gene therapies (ATMP, advanced therapy medicinal products) and small molecule drugs for immuno-oncology, autoimmune diseases, and vaccine adjuvant therapies. Accompanied several drug candidates (ATMP and small molecules) from development to CTA and IND submission. Strong background in preclinical development and regulatory requirements for CTA and IND submission Long-standing experience in program and project management.

Country

-

City

Germany

Industry

Biotechnology

Skill

Program Management, Gene Editing, Cell and Gene Therapy, Tumor Immunology, Regulatory Compliance, Pre-clinical Studies, Drug Discovery, Project Management, Assay Development, Immunology, Cell Biology, Biotechnology, Team Leadership, Lifesciences, High Throughput Screening, Laboratory Automation, Oncology, Biochemistry, Biopharmaceuticals, Cell Culture

Experience

DEBRA Research

Senior Director Preclinical Research

DEBRA Research

LinkedIn
2026-5 - Present · 5 mos

München

T-knife Therapeutics

Executive director, preclinical development

T-knife Therapeutics

LinkedIn
2021-11 - 2026-3 · 4 yrs 5 mos

Berlin, Deutschland

Miltenyi Biotec

Program-Manager Cellular Therapy

Miltenyi Biotec

LinkedIn
2014-6 - 2021-10 · 7 yrs 5 mos

Bergisch Gladbach

Program management of Cellular Therapy projects. ATMP (advanced therapy medicinal product) development from R&D, non-clinical to clinical trial applications (CTA, IND for CAR T cell products)

Miltenyi Biotec

Senior Project Manager

Miltenyi Biotec

LinkedIn
2011-10 - 2014-5 · 2 yrs 8 mos

Bergisch Gladbach

Leader of several R&D projects in the field of innate immunity and inflammation

Coley Pharmaceutical GmbH

Director Discovery & Development

Coley Pharmaceutical GmbH

2000-5 - 2011-9 · 11 yrs 5 mos

Head of the molecular biology, immunology and assay development laboratories Team lead of preclinical inflammation/autoimmunity project team focussing on lead identification, development and transfer to IND Principal Investigator of NIH- and BMBF-funded grants for adjuvant and cancer immunotherapy research Supported clinical development programs of TLR agonists for cancer therapy before and after IND

Boston University

Postdoctoral Fellow

Boston University

LinkedIn
1997-8 - 2000-4 · 2 yrs 9 mos

Boston, MA

Basic research in the field of signal transduction and apoptosis

Ludwig-Maximilians-Universität München

Postdoctoral Scientist

Ludwig-Maximilians-Universität München

LinkedIn
1995-8 - 1997-7 · 2 yrs

Munich, Germany

Functional and immunological characterization of potential tumor markers

Education

Ludwig-Maximilians-Universität München

Ludwig-Maximilians-Universität München

LinkedIn

Biochemie

1990 - 1995 · 5 yrs
Ludwig-Maximilians-Universität München

Ludwig-Maximilians-Universität München

LinkedIn

Chemistry

1984 - 1990 · 6 yrs

Marion Jurk's Contact Information

Email

******@***.com

Phone

(**) *** ****

Find the Right Leads
Find Verified Contact Data

Try with: Jensen Huang @ nvidia.com Click to autofill
LeadContact awards, five-star ratings, and GDPR compliance badges

What LeadContact does well

Find verified emails, phone numbers, and decision-makers with 98% accuracy.

Find Leads

Find Leads

Find the right people by company, role, industry, location, and more.

925M+ professional profiles

Find Leads
Find Emails

Find Emails

Access verified email addresses for your target contacts.

657M+ emails

Find Emails
Find Phone Numbers

Find Phone Numbers

Get cross-validated phone data from multiple top sources.

239M+ phone numbers

Find Phone Numbers

More Accurate. Lower Cost.

Find contact data in 1 tool with 98% accuracy

LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.

LeadContact Logo
Competitor Tools

All these = $289 per month

Great conversations start with the right contact.

It’s time to find yours.